Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study

por Kawase, Kazuhide, Vittitow, Jason L., Weinreb, Robert N., Araie, Makoto
Publicado 2016

Low‐dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials

por Ackerman, Stacey L, Torkildsen, Gail L, McLaurin, Eugene, Vittitow, Jason L
Publicado 2018

Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies

por Fong, Raymond, Cavet, Megan E, DeCory, Heleen H, Vittitow, Jason L
Publicado 2019

A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study

por Weinreb, Robert N, Ong, Tuyen, Scassellati Sforzolini, Baldo, Vittitow, Jason L, Singh, Kuldev, Kaufman, Paul L
Publicado 2015

A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin

por Couroux, Peter, Brkovic, Alexandre, Vittitow, Jason L., Israel, Robert J., Pamidi, Chinna, Patel, Jignesh, Barakat, Maxime
Publicado 2022